6-42564367-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001363705.2(UBR2):c.48G>C(p.Leu16Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,611,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001363705.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBR2 | NM_001363705.2 | c.48G>C | p.Leu16Phe | missense_variant | Exon 1 of 47 | ENST00000372901.2 | NP_001350634.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBR2 | ENST00000372901.2 | c.48G>C | p.Leu16Phe | missense_variant | Exon 1 of 47 | 5 | NM_001363705.2 | ENSP00000361992.1 | ||
UBR2 | ENST00000372899.6 | c.48G>C | p.Leu16Phe | missense_variant | Exon 1 of 47 | 1 | ENSP00000361990.1 | |||
UBR2 | ENST00000372903.6 | c.48G>C | p.Leu16Phe | missense_variant | Exon 1 of 12 | 1 | ENSP00000361994.2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152200Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1458962Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 725612
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.48G>C (p.L16F) alteration is located in exon 1 (coding exon 1) of the UBR2 gene. This alteration results from a G to C substitution at nucleotide position 48, causing the leucine (L) at amino acid position 16 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at